Keith Anthony Jones
Director · Humacyte, Inc.
IndividualBuying only
- 2026
- Sep 15, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Keith Anthony Jones files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kathleen Sebelius - $50K in HUMA purchases and sales in the last 12 months
- Dale A. Sander - $41K in HUMA purchases and sales in the last 12 months
- Shamik J. Parikh - $41K in HUMA purchases and sales in the last 12 months
- Michael T. Constantino - $10K in HUMA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Keith Anthony Jones?
Keith Anthony Jones is a corporate insider, tracked as Director of Humacyte, Inc. (HUMA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Keith Anthony Jones submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Keith Anthony Jones been buying or selling stock?
Recorded transactions: 3 open-market purchases ($30K) and 0 open-market sales across all tracked filings.
